AI-Driven Proteomics: Can Machine Learning Predict Disease Before Symptoms Even Appear?
The Protein Chip Market in 2026 is reaching a valuation of over $2.5 billion, fueled largely by the integration of "Agentic AI." This year, the most significant breakthrough isn't just the chip itself, but the software that reads it. New AI algorithms can now interpret the complex data generated by protein microarrays to spot "Subtle Signatures" of disease years before physical symptoms...
0 Comentários 0 Compartilhamentos 174 Visualizações 0 Anterior